A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022

Yupeng Xi1, Rui Liu2, Xing Zhang2

  • 1Department of General Internal Medicine, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

PubMed
Abstract

Insights

This bibliometric analysis reveals key trends in tumor microenvironment (TME) and metabolic reprogramming research. The United States leads in publications, with immunometabolism and tumor-associated macrophages as emerging hot topics.

Area of Science:

  • Oncology
  • Immunology
  • Metabolic Research

Background:

  • Cancer immunotherapy faces limitations, partly due to resistance mechanisms involving tumor microenvironment (TME) interactions.
  • Metabolic reprogramming within the TME significantly impacts anti-tumor immunity.
  • Limited research has comprehensively explored the intersection of TME and metabolic reprogramming.

Purpose of the Study:

  • To conduct a bibliometric analysis of research on metabolic reprogramming and the TME.
  • To identify current research status, popular topics, and trends over a 20-year period (2003-2022).

Main Methods:

  • Searched Web of Science Core Collection for relevant studies.
  • Utilized bibliometric and visual analysis tools including Bibliometrix, VOSviewer, and CiteSpace.
  • Analyzed publication trends, citation counts, cooperation networks, and keyword clusters.

Main Results:

  • A total of 4726 articles were published between 2003 and 2022, showing annual growth.
  • The United States is the leading country in this research area.
  • Key research clusters include TME, metabolic reprogramming, immunometabolism, and immunity, with recent focus on immunometabolism, glycolysis, immune cells, and tumor-associated macrophages.

Conclusions:

  • This study provides a comprehensive overview of metabolic reprogramming and TME research.
  • Highlights the growing importance of immunometabolism within the TME.
  • Recommends transdisciplinary approaches for future research in this promising field.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K